DanDrit Biotech A/S

DanDrit Biotech A/S is a Danish biotech company. We develop and manufacture cancer vaccines with the intent to launch innovative therapeutic and prophylactic treatments in Denmark and internationally. Our primary vaccine product, MelCancerVac®, will improve the patient immune responses against solid tumours and their metastases. MelCancerVac® will be administered as mono therapy as well as adjuvant (complementary) to other cancer treatments.

News